An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF

ClinicalTrials.gov ID: NCT01455402

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01455402. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Observational Study to Assess Respiratory Syncytial Virus (RSV)-Associated Illness in Adults With Chronic Obstructive Pulmonary Disease (COPD) and/or Congestive Heart Failure (CHF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this observational study is to determine the incidence of medically attended (inpatient or outpatient) acute respiratory illnesses or events leading to worsening cardiorespiratory status (ie, acute exacerbations of chronic obstructive pulmonary disease \[AECOPD\] or worsening CHF) associated with RSV infections in high-risk adults (ie, those with severe COPD and/or advanced CHF) across multiple consecutive RSV seasons.

Study identification

NCT ID: NCT01455402
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: MedImmune LLC; Industry
Enrollment: 476 participants

Conditions and interventions

Conditions

Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure

Interventions

Not listed

Eligibility (public fields only)

Age range: 50 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 2010 (Type not available)
Primary completion: May 2014 (Actual)
Completion: May 2014 (Actual)
Last update posted: Jul 9, 2014

2010 – 2014

United States locations

U.S. sites: 21
U.S. states: 14
U.S. cities: 21

Facility	City	State	ZIP	Site status
Research Site	Birmingham	Alabama	35294	—
Research Site	Fort Smith	Arkansas	72901	—
Research Site	Denver	Colorado	—	—
Research Site	Bay Pines	Florida	—	—
Research Site	Miami	Florida	—	—
Research Site	Marietta	Georgia	30060	—
Research Site	Council Bluffs	Iowa	51503	—
Research Site	Minneapolis	Minnesota	—	—
Research Site	Reno	Nevada	89502	—
Research Site	Buffalo	New York	14215-1199	—
Research Site	Mineola	New York	11501	—
Research Site	Rochester	New York	14621	—
Research Site	Chardon	Ohio	44024	—
Research Site	Beaver	Pennsylvania	15009	—
Research Site	Jefferson Hills	Pennsylvania	15025	—
Research Site	Pittsburgh	Pennsylvania	15213	—
Research Site	Nashville	Tennessee	35294	—
Research Site	Houston	Texas	77030	—
Research Site	Kingwood	Texas	77339	—
Research Site	Marshfield	Wisconsin	—	—
Research Site	Milwaukee	Wisconsin	53295	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01455402, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 9, 2014 · Synced Nov 15, 2026